stimulates smooth muscles and increases its motor activity
US patent 0337024, Allison Coffin, Joseph Harding, Leen Kawas, Phillip Uribe, "Novel Lead Compound for Otoprotection: Targeting HGF Signaling with Dihexa", issued 2015-11-26 "Dihexa" (PDF)
Why COA Documentation Matters for BPC-157 Research Materials
Supplies Needed Plan based on a 4-week protocol: Peptide Vials: 4 weeks 1 vial (70mg) Insulin Syringes (U-100): 28 syringes (1 per day) Bacteriostatic Water: 3 mL required 1 10 mL bottle Alcohol Swabs: 56 swabs recommend 1 100 pack Protocol Overview Goal: Investigate synergistic peptide activity in tissue repair, collagen signaling, and cellular regeneration pathways Schedule: Daily dosing for 4-16 weeks Follow with 24 week break Dose: 2.33 mg daily total blend Reconstitution: 3.0 mL per vial Storage: Lyophilized vials frozen
BPC-157: No significant meal timing requirements
BPC-157 acts during this window by binding to growth factor receptors on endothelial cells and fibroblasts, triggering intracellular signaling cascades that increase VEGF and FGF-2 expression by 300400% above baseline according to immunohistochemistry studies on rat tendon models
